Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules
2009; Wiley; Volume: 72; Issue: 6 Linguagem: Inglês
10.1111/j.1365-2265.2009.03733.x
ISSN1365-2265
AutoresLuca Giovanella, Marco Maffioli, Sergio Suriano, Romolo M. Dorizzi,
Tópico(s)Thyroid and Parathyroid Surgery
ResumoClinical EndocrinologyVolume 72, Issue 6 p. 852-853 Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules Luca Giovanella, Luca Giovanella Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Clinical Chemistry and Laboratory Medicine, Ente Ospedaliero Cantonale, Bellinzona, SwitzerlandSearch for more papers by this authorMarco Maffioli, Marco Maffioli Head and Neck Surgery, University Hospital “Fondazione Macchi”, Varese, ItalySearch for more papers by this authorSergio Suriano, Sergio Suriano Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, SwitzerlandSearch for more papers by this authorRomolo M. Dorizzi, Romolo M. Dorizzi Core Lab, Laboratorio Unico di AvR, Pievesestina di Cesena, FC Italy E-mail: [email protected]Search for more papers by this author Luca Giovanella, Luca Giovanella Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Clinical Chemistry and Laboratory Medicine, Ente Ospedaliero Cantonale, Bellinzona, SwitzerlandSearch for more papers by this authorMarco Maffioli, Marco Maffioli Head and Neck Surgery, University Hospital “Fondazione Macchi”, Varese, ItalySearch for more papers by this authorSergio Suriano, Sergio Suriano Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, SwitzerlandSearch for more papers by this authorRomolo M. Dorizzi, Romolo M. Dorizzi Core Lab, Laboratorio Unico di AvR, Pievesestina di Cesena, FC Italy E-mail: [email protected]Search for more papers by this author First published: 18 May 2010 https://doi.org/10.1111/j.1365-2265.2009.03733.xCitations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Elisei, R. (2008) Routine serum calcitonin measurement in the evaluation of thyroid nodules Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Practise and Research. Clinical Endocrinology and Metabolism, 22, 941–953. 2 D’Herbomez, M., Caron, P., Bauters, C. et al. (2007) Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. European Journal of Endocrinology, 157, 749–755. 3 Becker, K.L., Snider, R. & Nylen, E.S. (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Critical Care Medicine, 36, 941–952. 4 Algeciras-Schimnich, A., Preissenr, C.M., Theobald, P. et al. (2009) Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. Journal of Clinical Endocrinology Metabolism, 94, 861–868. 5 Verga, U., Ferrero, S., Vicentini, L. et al. (2007) Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocrine-related Cancer, 14, 393–403. Citing Literature Volume72, Issue6June 2010Pages 852-853 ReferencesRelatedInformation
Referência(s)